Editorial: serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab

Journal article

Open access

Peer reviewed

Laura Appleton and Andrew S. Day

Alimentary pharmacology & therapeutics, Vol.52(6), pp.1080-1081

01/09/2020

Handle:

https://hdl.handle.net/10523/36620

Abstract

Gastroenterology & Hepatology

Life Sciences & Biomedicine

Pharmacology & Pharmacy

Science & Technology

url

https://doi.org/10.1111/apt.15987View

Published (Version of record) Open

6 Record Views

Record Identifier: 9926529199901891
Title: Editorial: serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab
Creators: Laura Appleton
Andrew S. Day
Publication Details: Alimentary pharmacology & therapeutics, Vol.52(6), pp.1080-1081
Academic Unit: Paediatrics and Child Health (UOC)
Publisher: Wiley
Date published ; e-published: 01/09/2020
Language: English
Resource Type ; Subtype: Journal article